Juliane Ray, Vice President, Product Management, Medtech, Life Sciences & Healthcare, Clarivate, said: "DRG Commercial Analytics 360 was purpose-built to help medtech companies translate real ...

BANGI: The first phase of Malaysia's national Diagnosis-Related Group (DRG) system, focusing on minor illnesses in hospitals, is expected to be implemented by the end of 2025, Health Minister ...

In her own words, what “saved” her was neurostimulation – therapies such as electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) which use electricity to stimulate ...

DRG Commercial Analytics 360 equips commercial teams with the insights needed to navigate the complex U.S. provider landscape, engage key stakeholder, and improve both patient access and business ...

This upward trend reflects the growing importance of neurostimulation technologies in gastrointestinal (GI) disorder management, especially in drug-resistant cases of gastroparesis. Gastric electrical ...

Nexalin’s upcoming Gen-3 HALO Clarity™ device, currently under development for FDA submission, is a next-generation neurostimulation system that integrates advanced AI capabilities into both ...

Chicago, April 22, 2025 (GLOBE NEWSWIRE) -- The global FemTech Market was valued at US$ 56.50 billion in 2024 and is expected to reach US$ 206.84 billion by 2033, growing at a CAGR of 15.51% ...

Occipital nerve stimulation is widely considered to be the first choice neurostimulation procedure for chronic cluster headache. Hypothalamic stimulation is an invasive procedure for drug ...

EluPro, the first and only FDA-cleared antibiotic-eluting bioenvelope designed for use with cardiac implantable electronic devices and neurostimulators, was commercially launched earlier this year.

The two-year clinical trial, led by UCLA adjunct professor of child psychiatry Joseph O'Neill, will study whether a neurostimulation therapy may be an effective, at-home treatment option for these ...

EluPro, the first and only FDA-cleared antibiotic-eluting bioenvelope designed for use with cardiac implantable electronic devices (CIEDs) and neurostimulators, was commercially launched earlier this ...